• 제목/요약/키워드: Pharmaceutical Market

검색결과 189건 처리시간 0.027초

A Simple and Efficient Method to Determine Rivaroxaban in Rat Plasma Using Liquid-Liquid Extraction and LC-MRM

  • Lee, Hyo Chun;Kim, Dong Yoon;Choi, Min-Jong;Jin, Sung Giu;Choi, Yong Seok
    • Mass Spectrometry Letters
    • /
    • 제10권2호
    • /
    • pp.66-70
    • /
    • 2019
  • Rivaroxaban (RRN) is the first available active direct factor Xa inhibitor (anticoagulant) with oral administration. Due to its success in market, there have been efforts to develop various RRN formulations, and the development of good analytical methods for its in vivo evaluation is an essential prerequisite. Thus, here, a simple and efficient method to determine RRN in rat plasma using liquid-liquid extraction (LLE) and liquid chromatography and multiple reaction monitoring (LC-MRM) was presented. The use of ethyl acetate as the LLE solvent results appropriate extraction and purification of RRN and it also helps the significant reduction of rat plasma volume required for RRN quantitation. The developed method showed good analytical performance including specificity, linearity ($r^2{\geq}0.999$ within 0.5 - 500 ng/mL), sensitivity (the lower limit of quantitation at 0.5 ng/mL), accuracy (89.3 - 107.0%), precision (${\geq}12.7%$), and recovery (89.2 - 105.7%). Additionally, RRN in sample extracts showed good stability. Finally, the applicability of the validated method to the PK evaluation of RRN was confirmed after its oral administration to normal rats. The present method is the first analytical method employing LLE for the simple and efficient extraction and purification of RRN in rat plasma. Therefore, the present method can contribute to the development of new RRN formulations as well as to the monitoring of RRN in special clinical situations through its efficient determination in various samples with or without minor modification.

사용 환경에 따른 캠핑용 조리 기구로부터 유해금속 용출의 변화 (Influence of usage environment from camping cooking utensils on migration of hazardous metals)

  • 이진희;김지연;박예슬;박상규;이재호;윤종호;김경태;한기동
    • 한국식품저장유통학회지
    • /
    • 제24권8호
    • /
    • pp.1094-1102
    • /
    • 2017
  • 대구시내 대형마트에서 유통되고 있는 스테인레스, 경질알루미늄, 연질알루미늄 재질 코펠 및 불소수지 코팅 불판에 대해 0.5% citric acid 용액에서 용출되는 유해 금속을 유도결합플라즈마 발광광도측정기(ICP-OES)로 측정한 결과, 식품용 기구 및 용기 포장 공전에 기준이 설정된 납, 카드뮴, 비소, 니켈의 경우는 모두 적합한 것으로 나타났다. 그러나 용출 용액과 사용 환경에 따라 그 용출 정도에 차이가 있는 것으로 나타났다. 증류수, 0.5% citric acid 용액, 1% NaCl 용액 등 용출 용액을 달리하여 30분간 가열한 뒤 평균 용출량을 비교한 결과, 증류수에서 경질알루미늄 재질 코펠의 알루미늄 용출량이 0.007 mg/L 수준이었으나, 0.5% citric acid 용액에서는 스테인레스 재질 코펠은 0.021 mg/L, 경질알루미늄 재질 코펠은 51.97 mg/L, 연질알루미늄 재질 코펠은 24.89 mg/L, 불소수지 코팅 불판은 0.040 mg/L로 증류수와 1% NaCl 용액에서의 용출량보다 높았다. 1% NaCl 용액에서 비소는 스테인레스와 연질알루미늄 재질 코펠 0.006 mg/L, 경질알루미늄 재질 코펠 0.008 mg/L로 증류수와 0.5% citric acid 용액에서의 용출량보다 다소 높게 용출되었다. 0.5% citric acid 용액에서 니켈이 스테인레스 재질 코펠이 0.007 mg/L로 증류수와 1% NaCl 용액에서의 용출량보다 다소 높게 용출되었는데, 이는 스테인레스 코펠의 니켈 조성 특성 때문으로 사료된다. 카드뮴은 모든 용액에서 검출되지 않았다. 물리적 스크래치를 가한 후의 용출 용액에 따른 유해 금속 용출량은 스크래치를 가하기 전보다 모든 용액에서 전반적으로 증가하는 것으로 조사되었다. 특히, 0.5% citric acid 용액에서는 스테인레스와 경질알루미늄 재질 코펠에서 카드뮴이 용출되는 것으로 나타났다. 용출 시간에 따른 유해 금속 용출량 변화를 살펴보면, 증류수에서는 경질알루미늄, 연질알루미늄 재질 코펠과 불소수지 코팅 불판의 알루미늄 용출량이 증가하였다. 0.5% citric acid 용액에서는 스테인레스, 경질알루미늄, 연질알루미늄 재질 코펠의 니켈과 알루미늄 용출량이 증가하였고, 불소수지 코팅 불판은 납, 비소, 알루미늄 용출량이 증가하였다. 1% NaCl 용액에서는 스테인레스, 경질알루미늄 재질 코펠과 불소수지 코팅 불판의 비소 용출량이 증가하였고, 연질알루미늄 재질 코펠의 비소와 알루미늄 용출량이 증가하였다.

IPO 전후 혁신의 효율성 비교 연구: 의약산업 중심으로 (Comparison of Innovation Efficiency of Pre-IPO and Post-IPO in Korea: Case of Pharmaceutical Industry)

  • 김은희
    • 기술혁신연구
    • /
    • 제24권1호
    • /
    • pp.143-167
    • /
    • 2016
  • 본 연구에서는 IPO시점을 전후하여 기업의 혁신 활동과 성과의 변화에 대한 분석을 목적으로 연구개발 투자 비중이 높은 의료 및 의약 분야의 코스닥 IPO 상장 기업을 대상으로 7개의 투입, 산출 모형에 대한 효율성 분석과 비교를 실시하였다. 의약분야 기업의 IPO 전후 3년간의 혁신활동 효율성을 측정하고 차이를 분석하기 위해 DEA모형을 적용하였다. 본 논문의 주요한 결과는 첫째, 의약분야의 IPO 기업의 창업에서 IPO까지 평균 12.86년이 소요되었고, 혁신활동은 평균적으로 IPO 이전보다 더욱 활발해져 연구개발 투자액이 증가되었다. 출원특허의 수는 IPO 이전 3년 동안 8.43개에서 IPO 이후 3년 동안에는 상장기업 평균 16.67로 급증하였으며 기업의 기술 영역도 전후 3년 동안 상장기업 평균 11개에서 22개 기술분야로 크게 확대되는 모습을 보였으나, 재무적 측면에서 성장 추이와 수익성은 IPO 이전보다 낮아졌다. 둘째, 연구개발 투자와 특허출원 활동에 대한 재무적인 성과는 IPO 이후 효율성이 모두 약화되었으며, 최종적인 성과에 이르기까지 투자와 활동을 분리하여 연구개발투자에 따른 특허 출원 성과, 특허 출원 활동에 따른 재무적인 성과에 대한 효율성 역시 IPO 이전보다 모두 낮아진 것으로 분석되었다. 셋째, 특허활동에 따른 재무성과에 대한 효율성은 연구개발 투자에 따른 특허 출원 성과, 연구개발투자와 특허활동에 따른 재무성과에 대한 효율성에 비해 낮았고, 특히, IPO 이후 특허활동에 따른 재무성과의 비효율성은 규모의 비효율성으로 인해 발생되었음이 분석되었다. 마지막으로, 본 연구에서 IPO 이후 전체적인 효율성 하락은 IPO를 퉁한 연구개발투자 확대가 시장의 재무적 성과로 이어지지 못하였고, IPO 이후 전체적인 비효율성은 연구개발투자를 통한 혁신의 결과 도출 단계보다는 혁신활동의 결과물이 시장의 성과를 이끌어 내는 데 나타나는 비효율성으로 인한 것으로 분석되었다.

반려동물애호가 대상 동물의약품 사용 및 동물약국 이용 현황 조사 (A Survey on the use of veterinary medicines and veterinary pharmacies by companion animal lovers)

  • 안화영;김현지;허지선;여승언;김유환;천영주;임성실
    • 한국임상약학회지
    • /
    • 제32권1호
    • /
    • pp.47-56
    • /
    • 2022
  • Background: In modern society, the number of households raising companion animals increases, and the market for veterinary medicines is expanding even more. This study aims to investigate the perception of companion animal lovers' veterinary medicines, the necessity of specific guidance by pharmacists for veterinary medicines, the role of pharmacists at veterinary pharmacies, and ways to fulfill that role. Methods: This study evaluated veterinary medicines and medication guidance through Google online questionnaire targeting pet-lovers from December 20, 2021, until January 19, 2022. The questions consist of 1) characteristics of petlovers, 2) purchase history and drug recognition of veterinary drugs, 3) use of veterinary vaccines, 4) use of diagnostic kits, and 5) guidance of veterinary medicines by local pharmacists. Results: The respondents' experience purchasing veterinary drugs was as high as 94.4%. The most purchased drug was heartworm-preventing products, and vaccination was performed mainly at veterinary clinics (veterinarians). The respondents primarily purchased veterinary medicines for companion animals at veterinary hospitals and did not know the name of the drugs which they bought. In addition, respondents expected to receive specific information on veterinary medicines from pharmacists. Conclusion: As the number of veterinary pharmacies in the community will increase with the expansion of the companion animal market, pharmacists should play their role as experts in veterinary medicines through systematic and continuous professional education.

Formulation and Sensory Evaluation of Granule and Tablet from Lotus Rhizome(Nelumbo nucifera Rhizome)

  • Karki, Rajendra;Bang, Kyu-Ho;Kim, Dong-Wook
    • 한국자원식물학회지
    • /
    • 제21권1호
    • /
    • pp.103-109
    • /
    • 2008
  • Nelumbo nucifera root(NNR) is used to clear summerheat(暑熱), bear Yang(陽) upwards and stop bleeding as mentioned in traditional Korean medicine. Also, it has been known that NNR is effective for lowering blood pressure and hyperlipidemia. The rhizome is considered to be nutritive, demulcent, diuretic and cholagogue and is used to treat piles, dyspepsia and diarrhea. An increasingly growing market for nutraceuticals and functional foods has triggered the study on natural sources for nutraceuticals, health foods and functional foods. But rhizome was inconvenient to formulate liquid dosage form(extract) by way of hot water because of its limited storage. Also the majority of the consumers have a complaint against the dosage. The purpose of this study was to develop the functional materials from NNR without side effects. We formulated the solid dosage form viz tablet and granule from the lotus root. Sensory evaluation was performed in terms of smell, taste, color and overall of lotus root and all colored forms(brown, dark brown, light green and yellow) of tablet and granule to evaluate the acceptability of the formulated tablets and granules. In sensory evaluation, among the formulated tablets and granules, light green granules obtained best score overall and yellow tablets showed the overall improved acceptability. In conclusion, lotus rhizome could be recommended as functional food. Further studies to clarify bioactive functions of Nelumbo nucifera in experimental animal model on atopic dermatitis are in progress.

Rheumatiod Arthritis: An Updated Overview of Latest Therapy and Drug Delivery

  • Kesharwani, Disha;Paliwal, Rishi;Satapathy, Trilochan;Paul, Swarnali Das
    • 대한약침학회지
    • /
    • 제22권4호
    • /
    • pp.210-224
    • /
    • 2019
  • Rheumatoid arthritis is a severe autoimmune disorder, related to joints. It is associated with serious cartilage destruction. This causes disability and reduces the excellence of life. Numerous treatments are existed to combat this disease, however, they are not very efficient and possess severe side effects, higher doses, and frequent administration. Therefore, newer therapies are developed to overcome all these limitations. These include different monoclonal antibodies, immunoglobulins, small molecules used for immunotherapy and transgenes for gene therapy. One of the main goals of these new generation therapeutics is to address the underlying distressing biological processes by specifically targeting the causative agents with fewer systemic side effects and greater patient console. It is very fortuitous that loads of progressive investigations are going on in this field and many of them have entered into the successful clinical trial. But till date, a limited molecule has got FDA clearance and entered the market for treating this devastating disease. This review highlights the overview of conventional therapy and advancements in newer therapeutics including immunotherapy and gene therapy for rheumatoid arthritis. Further, different novel techniques for the delivery of these therapeutics of active and passive targeting are also described.

Bioconversion of Dairy Processing Waste into Value-Added Chemicals

  • 김동식
    • 환경정책연구
    • /
    • 제2권2호
    • /
    • pp.65-79
    • /
    • 2003
  • More than 145 million tons of liquid whey is produced world-wide as dairy processing waste per year, and half of it is discarded without proper treatment. Due to its high nutrient value, the environmental impact can be significant. Bioconversion of cheese whey can provide an effective way to reduce the waste and, at the same time, generate economically attractive value-added chemicals. In this study, cheese whey was fermented with P. acidipropionici to produce propionic acid which has a high market value for chemical and pharmaceutical industries. In order to specifically enhance propionic acid production, acetic acid production was suppressed using o-iodosobenzoic acid as an enzyme inhibitor. When grown in the presence of the inhibitor, propionic acid production rate increased by a factor of 2 while acetic acid production rate decreased by a factor of 3. Furthermore, when 0.3 mM of o-iodosobenzoic acid was used, the incipient stage(creeping growth period) was considerably reduced. Therefore, the inhibitor helps the cells begin to grow earlier and speed up the production of propionic acid. Although the production rate of propionic acid effectively increased, the final concentration(or production yield) remained unchanged due to product inhibition. Methods that can reduce product inhibition are being tested combined with o-iodosobenzoic acid to optimize both the production rate and yield. The results are expected to be informative for controlling the other byproducts for other applications.

  • PDF

Rifampicin과 Ofloxacin에 내성인 Bifidobacterium bifidum 균주의 개발 (Development of Bifidobacterium bifidum Strains Resistant to Rifampicin and Ofloxacin)

  • 정영자;전명인;강창율;김병각;최응칠
    • 약학회지
    • /
    • 제38권6호
    • /
    • pp.763-769
    • /
    • 1994
  • Bifidobacterium bifidum, one strain of medical preparation being on the market for human intestinal disorders, was sensitive to rifampicin and fluoroquinolones. If this preparation is taken with rifampicin and fluoroquinolones, its therapeutic effect can't be expected. Serial passage of B. bifidum RFR61, which was obtained by MNNG mutation method, on agar with 2-fold minimal inhibitory concentration of ofloxacin produced B. bifidum OFR9 with minimal inhibitory contentrations of fluoroquinolones up to $4{\sim}256-fold$ higher than that for the original strain. B. bifidum OFR9 produced almost the same amount of organic acid as parental strain. This strain showed growth inhibitory activity against E. coli NM522, Shigella dysenteriae ATCC9752 and E. coli 078. No inactivations of rifampicin and ofloxacin by this resistant mutant strain were found.

  • PDF

일제강점기 매약을 통해 본 한약의 제형 변화와 새로운 한약 처방의 경향성에 대한 고찰 (A study of how proprietary medicines during the Japanese colonial period led to transforms in Korean medicine and Korean medicine prescriptions)

  • 황지혜;김남일
    • 한국의사학회지
    • /
    • 제33권1호
    • /
    • pp.99-112
    • /
    • 2020
  • In this study, we examine the changes to Korean medicine that occurred when 'proprietary medicines' (賣藥) swept through the pharmaceutical market during the Japanese occupation (1910-1945 C.E.). Proprietary medicine during the Japanese colonial period took various forms including ready-made, over-the-counter, patent, and nostrum type pharmaceuticals. This paper examines how Korean medicine, which was the dominant form of medicine during the Joseon Dynasty, was forced to adapt to the rise of proprietary medicines. We found that the prescription of Korean medicine herbal decoctions became more like proprietary medicine in the way that they were formulated. In addition, prescriptions in Korean medicine books were reformulated with prescriptions and medicines from outside the tradition. Proprietary medicines, many of which were made with secret recipes handed down in a family, also attracted attention. Such prescriptions were made famous through advertisements and further influenced future Korean medicine doctors. New prescriptions took advantage of the trust and authority existing in traditional Korean medicine by introducing ginseng and traditional medicinal herbs such as deer antler velvet (鹿茸, Cervi Parvum Cornu). This paper argues that proprietary medicine of the Japanese colonial period distorted the concept of traditional herbal medicine.

Structure and Function of the Genes Involved in the Biosynthesis of Carotenoids in the Mucorales

  • Iturriaga, Enrique A.;Velayos, Antonio;Eslava, Arturo P.
    • Biotechnology and Bioprocess Engineering:BBE
    • /
    • 제5권4호
    • /
    • pp.263-274
    • /
    • 2000
  • Carotenoids are widely distributed natural pigments which are in an increasing demand by the market, due to their applicatins in the human food, animal feed, cosmetics, and pharmaceutical industries. Although more than 600 carotenoids have been identified in nature, only a few are industrially important (${\beta}$-carotene, astaxanthin, lutein or lycopene). To date chemical processes manufacture most of the carotenoid production, but the interest for carotenoids of biological origin is growing since theire is an increased public concern over the safety of artificial food colorants. Although much interest and effort has been devoted to the use of biological sources for industrially important carotenoids, only the production of biological ${\beta}$-carotene and astaxanthin has been reported. Among fungi, several Mucorales strains, particularly Blakeslea trispora, have been used to develop fermentation processes for the production of ${\beta}$-carotene on almost competitive cost-price levels. Similarly, the basidiomycetous yeast Xanthophyllomyces dendrorhous (the perfect state of Phaffia rhodozyma), has been proposed as a promising source of astaxanthin. This paper focuses on recent findings on the fungal pathways for carotenoid production, especially the structure and function of the genes involved in the biosynthesis of carotenoids in the Mucorales. An outlook of the possibilities of an increased industrial production of carotenoids, based on metabolic engineering of fungi for carotenoid content and composition, is also discussed.

  • PDF